MOLECULAR PARTNERS AG Gain Loss On Remeasurement Of Net Defined Benefit Liability Asset
MOLECULAR PARTNERS AG (MOLN) reported Gain Loss On Remeasurement Of Net Defined Benefit Liability Asset of -CHF 3.81 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-12.
Financial Statements › Income Statement › Other Income
ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset · last filed 2026-03-12
| Period end | Gain Loss On Remeasurement Of Net Defined Benefit Liability Asset 12 month |
|---|---|
| 2025-12-31 | -3.81M CHF 20-F · filed 2026-03-12 |
| 2024-12-31 | -485.00K CHF 20-F · filed 2026-03-12 |
| 2023-12-31 | -1.98M CHF 20-F · filed 2025-03-06 |
| 2022-12-31 | 5.33M CHF 20-F · filed 2024-03-14 |
| 2021-12-31 | 8.01M CHF 20-F · filed 2023-03-09 |
| 2020-12-31 | -1.51M CHF 20-F · filed 2022-03-15 |